Longitudinal changes of left ventricular filling pressure and N-terminal pro-brain natriuretic peptide on chronic hemodialysis

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Background: Left ventricular filling pressure (LVFP) is related to the longterm prognosis in end-stage renal disease. The aims of this study were to evaluate the time course of the changes in LVFP, the predictors for the changes of LVFP, and the plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) levels as indicators for the changes of LVFP in chronic hemodialysis (HD). Methods: This study was designed prospectively. Doppler echocardiographic examinations andmeasurement of plasma NT-pro-BNP-levels were performed in 37 consecutive patients on chronic HD and repeated at median of 43 months later. A ratio of peak early transmitral flow velocity to peak early diastolic mitral annular velocity (E/Em), an estimate of LVFP, was calculated. Results: E/Em ratios were significantly increased during the follow-up period. Inmultivariate analysis, age and changes of LVMI were independently associated with the changes of E/Em ratios. The plasma NT-proBNP levels were independently associated with E/Em at baseline and at the end of follow-up. The changes of plasma NT-proBNP levels were independently associated with changes of E/Emratios (β-coefficient 0.453, p = 0.003). Conclusions: Our data suggest that the deterioration of LVFP parallels with the progression of LV hypertrophy. Monitoring the plasma NT-proBNP levels might be useful for the detection of the LVFP changes in chronic HD.

Original languageEnglish
Pages (from-to)190-197
Number of pages8
JournalClinical Nephrology
Volume74
Issue number3
DOIs
StatePublished - Sep 2010

Keywords

  • Doppler echocardiography
  • ESRD
  • Hemodialysis
  • Left ventricular filling pressure
  • N-terminal pro-brain natriuretic peptide

Fingerprint

Dive into the research topics of 'Longitudinal changes of left ventricular filling pressure and N-terminal pro-brain natriuretic peptide on chronic hemodialysis'. Together they form a unique fingerprint.

Cite this